Who Makes Up the Target Market of Avanos Company?

How does Avanos Medical target clinicians and hospitals in pain management and digestive care?

Avanos Medical focuses on clinicians and hospital systems that prioritize clinical-preference devices for pain management and enteral nutrition. The shift after the 2024 respiratory divestiture has concentrated revenue toward higher-margin, outcome-driven products; FY2025 signals show continuing revenue mix improvement and tighter customer segmentation.

Clinicians and specialty hospitals drive repeat purchase and training-led adoption; buying leans on clinical outcomes and protocol alignment, not price alone. See product positioning in Avanos Marketing Mix 4P.

Avanos Medical's core customers are institutional healthcare buyers – acute care hospitals, ambulatory surgery centers (ASCs), and specialized clinics – and clinical specialists such as gastroenterologists, anesthesiologists, orthopedic surgeons, and NICU teams who drive device selection. Home healthcare providers and DME distributors form a growing secondary base for enteral feeding and chronic-care supplies.

Main Customer Group

Acute care hospitals and ASCs are the primary buyers of Avanos products because they purchase at scale for perioperative and pain-management needs; hospital value analysis committees (VACs) and procurement teams control purchasing decisions.

Secondary Customer Groups

Home healthcare agencies, durable medical equipment distributors, and outpatient pain clinics buy enteral feeding devices and wound-care products for chronic patients, expanding the Avanos target audience beyond hospitals.

Customer Type and Market Role

Avanos serves a mixed B2B and B2B2C market: institutional purchasers (hospitals, health systems, clinics) and clinical influencers (physicians, nurses) shape demand, while DME and home-health channels reach end patients.

Most Commercially Important Segment

As of early 2025, digestive health and enteral feeding represented the largest revenue driver at roughly 60 – 65% of total revenue, making gastroenterologists and NICU teams the most commercially important customer segment.

Key buyers include VACs, procurement managers, and supply-chain teams; clinical influencers – orthopedics, anesthesia, gastroenterology – drive product selection and utilization.

Core Customers: Hospitals, Clinicians, and Home-Health Channels

Avanos target market centers on institutional hospital customers and clinical specialists, with home-health and DME as a strategic secondary channel; enteral feeding dominates revenue in 2025.

• Acute care hospitals and ASCs as main purchasers
• Home healthcare agencies and DME distributors as secondary buyers
• Mixed B2B/B2B2C model – procurement teams plus clinical influencers
• Enteral feeding (digestive health) the top commercial segment in 2025

For competitive context and buyer-location guidance, see Competitive Landscape of Avanos Company

Avanos SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Patients and healthcare providers need reliable, clinically effective devices that reduce opioid use, speed recovery, and lower readmissions; institutional buyers seek cost-effective products that improve CMS quality metrics and HCAHPS scores. Demand in 2025 is driven by opioid-sparing pain solutions, durable enteral feeding devices, and wound-care products that cut complication rates and total cost of care.

Reduce opioid use and improve recovery

Providers buy Avanos products to provide localized, non-systemic pain control that shortens hospital stays and enables earlier mobilization after surgery.

Buyers prioritize clinical effectiveness and cost

Hospitals and procurement managers choose based on demonstrated efficacy, lower total cost of care, and alignment with CMS reimbursement-linked quality measures.

Trust and clinician confidence matter

Surgeons and pain-clinic clinicians prefer brands with clear outcomes data and predictable performance that reduce narcotic exposure for patients.

Reliability and patient comfort drive enteral device choice

Pediatric and adult caregivers value enteral feeding tubes that minimize skin irritation and accidental dislodgement, improving long-term adherence and fewer replacements.

Repeat demand tied to outcomes and support

High product reliability, clinical training programs, and supply-chain availability support repeat purchases by hospitals, home-health agencies, and distributors.

Clear reason Avanos wins procurement

Avanos wins where devices demonstrably reduce complications, support opioid-sparing pathways, and help hospitals meet CMS quality benchmarks tied to reimbursement.

Key takeaway: Avanos target market spans hospitals, pain clinics, home-health agencies, and neonatal units that prioritize opioid-sparing pain management, durable enteral feeding solutions, and cost-effective wound care.

What Customers Need and Why They Buy

Avanos customers prioritize clinical outcomes, cost-efficiency, device reliability, and supplier support; procurement decisions are driven by CMS-linked quality metrics and clinician preference for opioid-sparing therapies.

• Main need: effective, localized pain control that reduces opioid use and readmissions
• Strongest practical driver: measurable impact on total cost of care and CMS/HCAHPS metrics
• Emotional factor: clinician trust in predictable clinical performance
• Core reason for choice: proven clinical outcomes and supply reliability

What These Customers Need and Why They Buy: The demand for Avanos Medical products is driven by clinical efficacy, economic efficiency, and the shift to opioid-sparing pain management; On-Q and Coolief address narcotic reduction and faster mobilization, Mic-Key addresses enteral-feeding reliability and comfort, and institutional buyers prioritize devices that help meet CMS quality benchmarks and improve HCAHPS-linked reimbursement – see Mission, Vision, and Core Values of Avanos Company

Avanos PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Avanos Medical finds its target market most concentrated in North America, driven by the United States where over 80 percent of net sales came from in fiscal 2025; demand is strongest in integrated delivery networks (IDNs) and outpatient surgical clinics, especially Sun Belt regions with aging populations.

Main Market: North America dominates

North America, led by the United States, is the primary Avanos target market because it accounts for roughly 80 – 85 percent of revenue in 2025 and concentrates Avanos customers in large IDNs and ASCs where enteral, wound care, and pain products are procured.

Secondary Markets: Europe and Asia – Pacific

Internationally Avanos sells in about 90 countries, with Europe and Asia – Pacific supplying the remaining 15 – 20 percent of net sales in 2025; these markets are heavier in hospital customers and distributor-led channels.

Where Avanos Is Strongest: Outpatient and IDN penetration

Avanos appears strongest in outpatient surgery centers (ASCs) and IDNs where portable, minimally invasive devices see higher utilization; revenue mix skews to wound care, enteral feeding, and pain management product lines.

Growing Demand: Shift to outpatient care

Demand is growing fastest in ASCs and ambulatory clinics in 2025/2026 as complex procedures move out of inpatient hospitals, benefiting Avanos target audience for enteral feeding devices and wound care products in ambulatory and home settings.

Regional mix shows heavy U.S. reliance but diversified distributor and hospital customers abroad; Avanos medical device buyers include procurement managers, clinicians, nurses, and medical device distributors in hospitals, ASCs, and home healthcare agencies – see more in this article: How Avanos Company Works and Makes Money

Avanos Business Model Canvas

• Complete Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Avanos Medical grows and retains customers via a razor-and-blade model, targeted R&D, a specialized direct sales force, and selective M&A to broaden clinical footprints and cross-sell across specialties; in 2025 the company reinforced digital caregiver engagement and product extensions to defend share versus generics.

How Avanos Expands Its Customer Base

Avanos target market expansion relies on direct hospital and clinic selling, clinical training that embeds products into SOPs, and M&A (eg, Diros integration) to add adjacent pain and wound-care buyers; this converts hospital customers into multi-category purchasers.

Customer Retention Drivers

High switching costs for enteral feeding ports (Mic-Key) create long repeat demand for replacement tubes and accessories, while clinical support, warranty/validation data, and supply-chain relationships with procurement managers reduce churn.

Loyalty, Repeat Demand, and Customer Depth

Recurring revenue comes from consumables and accessories sold into the same patient lifetime; loyalty deepens as clinicians, nurses, and home-health agencies standardize on Avanos devices and stocking protocols.

Strongest Customer-Base Growth Lever

The core lever is the enteral feeding ecosystem: initial device placement creates years of aftermarket consumable revenue and captures Avanos medical device buyers across hospitals, home healthcare, and neonatal intensive care units.

Avanos converts clinical adoption into durable revenue by training clinicians, aligning with procurement cycles, and using targeted M&A to reach new Avanos target audience segments; see more on Ownership of Avanos Company for context: Ownership of Avanos Company

Avanos Marketing Mix

• Covers Marketing Mix Analysis in Details
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔